Mov Disord Vol 35, Suppl 1 Archives - Page 124 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Stiff person syndrome and acethylcoline receptors ganglionic neuronal antibodies
J. Lester, J. Cojab, E. Klériga (Huixquilucan, Mexico)
Objective: Describe a case of stiff person syndrome and positivity for acetylcholine receptors ganglionic neuronal antibodies, not reportes before in stiff person syndrome. Background: Acetylcholine…
MDS Virtual Congress 2020
Substantianigral involvement on Tc99mDaTSPECT-a novel and under recognised imaging finding in Parkinsonian Disorders
S. Siddiqui, C. Nagaraj, J. Saini, P. Singh, R. Yadav, P. Pal (Bengaluru, India)
Objective: To assess feasibility of identifying SN involvement on DaTi, correlate with laterality of motor symptoms and compare with loss of nigrosome-1 hyperintensity on SWI . Background:…
MDS Virtual Congress 2020
Racial and Geographic Disparities in Parkinson’s Disease Patients with Gastrostomy Feeding Tube Placement
D. Kim, Z. Kunicki, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)
Objective: We sought to analyze a national database to examine how rates of gastrostomy tube (GT) placement in Parkinson's disease (PD) differ by race and…
MDS Virtual Congress 2020
Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease
D. Smith, P. Donaghy, B. Galna, A. Yarnall, J.P Taylor, D. Burn, A. Thomas, L. Rochester, R. Mc Ardle, R. Lawson (Newcastle upon Tyne, United Kingdom)
Objective: To compare Neuropsychiatric symptoms (NPS) in participants with Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD), dementia with Lewy bodies (DLB), Alzheimer’s disease (AD)…
MDS Virtual Congress 2020
Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease
N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)
Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association…
MDS Virtual Congress 2020
Behavioral and Psychological Symptoms in Patients with Movement Disorders
M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)
Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…
MDS Virtual Congress 2020
Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality
P. Myers, J. Jackson, A. Clover, C. Lessov-Schlaggar, E. Foster, J. Perlmutter, M. Campbell (St. Louis, MO, USA)
Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…
MDS Virtual Congress 2020
Hand Fine Motor Performance Capacity is Associated with the Cognition in People with Moderate to Advanced Parkinson’s disease
S. Tan, C.T Hong, T.H Liou (New Taipei City, Taiwan)
Objective: This study aims to investigate the association between the hand fine motor performance with the cognitive dysfunction in people with moderate and severe PD.…
MDS Virtual Congress 2020
Parkinson’s disease polygenic risk score and brain structure in neurologically healthy individuals
N. Abbasi, L. Krohn, U. Vainik, Z. Gan-Or, A. Dagher (Montreal, QC, Canada)
Objective: To investigate the relationship between Parkinson’s disease-polygenic risk score (PD-PRS) and brain morphology in a large sample of healthy individuals. Background: PD is caused…
MDS Virtual Congress 2020
Beta-Glucocerebrosidase Activity in GBA-linked Parkinson’s Disease: The Type of Mutation Matters
Y.E Huh, M.S Chiang, J. Locascio, Z. Liao, G. Liu, K. Choudhury, Y. Kuras, I. Tuncali, A. Videnovic, A. Hunt, M. Schwarzschild, A. Hung, T. Herrington, M. Hayes, B. Hyman, A.M Wills, S. Gomperts, J. Growdon, S. Sardi, C. Scherzer (Boston, MA, USA)
Objective: To test the relationship between clinically relevant types of GBA mutations (none, risk variants, mild mutations, severe mutations) and beta-glucocerebrosidase activity in patients with…